DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Flovent (Fluticasone Propionate Inhalation) - Summary

 
 



FLOVENT SUMMARY

The active component of FLOVENT 44 mcg Inhalation Aerosol, FLOVENT 110 mcg Inhalation Aerosol, and FLOVENT 220 mcg Inhalation Aerosol is fluticasone propionate, a glucocorticoid.

FLOVENT Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy. It is also indicated for patients requiring oral corticosteroid therapy for asthma. Many of these patients may be able to reduce or eliminate their requirement for oral corticosteroids over time.

FLOVENT Inhalation Aerosol is NOT indicated for the relief of acute bronchospasm.


See all Flovent indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Flovent (Fluticasone Inhalation)

Worldwide Trends in Occupational Allergy and Asthma
Source: Medscape Allergy & Clinical Immunology Headlines [2016.05.25]
How has the occurrence of work-related allergy and asthma changed in recent years? This new article examines the worldwide trends.
Current Opinion in Allergy and Clinical Immunology

Strategy for depleting immune cells implicated in asthma-associated inflammation
Source: Respiratory / Asthma News From Medical News Today [2016.05.20]
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing.

New data show that tiotropium helps children with their asthma symptoms by improving lung function in comparison to placebo
Source: Respiratory / Asthma News From Medical News Today [2016.05.18]
New data from the Phase III VivaTinA-asthma® study show that when used as an add-on to maintenance asthma therapy (inhaled corticosteroid, ICS, or ICS plus another maintenance therapy)...

Capitalizing on a teachable moment motivates parents of kids with asthma to quit smoking
Source: Alcohol / Addiction / Illegal Drugs News From Medical News Today [2016.05.17]
Parents who smoke are more likely to quit smoking after receiving motivational smoking cessation counseling following a "teachable moment" (TM) such as witnessing their child experience an asthma...

Is a written asthma action plan for children necessary?
Source: Respiratory / Asthma News From Medical News Today [2016.05.16]
Parents of children with asthma need ongoing education and guidance on this chronic condition and how to prevent and manage symptoms, but does a written asthma action plan improve outcomes more than...

more news >>

Published Studies Related to Flovent (Fluticasone Inhalation)

Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. [2014]
esophagitis (EoE) and analyzed esophageal transcriptomes to identify mechanisms... CONCLUSIONS: Daily administration of a high dose of FP induces histologic

Fluticasone impact on airway dendritic cells in smokers: a randomized controlled trial. [2013]
DCs in smokers are unknown... CONCLUSIONS: Resistance to ICS monotherapy in smokers might in part be due to

An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis. [2013]
Intranasal corticosteroids are widely prescribed for the treatment of perennial allergic rhinitis (PAR). The aim of this analysis was to determine whether the beneficial effects of once-daily (q.d.) fluticasone furoate nasal spray (FFNS) effectively improved individual nasal symptoms of PAR...

MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. [2012]
Many patients with allergic rhinitis (AR) have uncontrolled symptoms despite available treatment options. This study was designed to evaluate the efficacy and safety of MP29-02 (a novel intranasal formulation of fluticasone propionate [FP] and azelastine [AZ] hydrochloride), compared with monotherapy with FP, AZ, and placebo sprays for the treatment of seasonal allergic rhinitis (SAR)...

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. [2011.10.06]
ABSTRACT: BACKGROUND: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and evening), for 8 weeks in patients with persistent asthma... CONCLUSIONS: FF at total daily doses of 200 mcg or 400 mcg was significantly more effective than placebo. FF 400 mcg once daily in the evening had similar efficacy to FF 200 mcg twice daily and all FF regimens had a safety tolerability profile generally similar to placebo. This indicates that inhaled FF is an effective and well tolerated once-daily treatment for mild-to-moderate asthma. TRIAL REGISTRATION: NCT00398645.

more studies >>

Clinical Trials Related to Flovent (Fluticasone Inhalation)

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth [Recruiting]
Children with mild persistent asthma that have asthma symptoms once or twice a week and use a daily controller, while children with mild intermittent asthma rarely have asthma symptoms and do not use a daily controller. Inhaled corticosteroids are the standard treatment for mild peristent asthma. The purpose of this study is to measure children rate of growth while on different inhaled corticosteroids.

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma [Completed]
This purpose of this study is to show the superiority and long term safety and efficacy of adding a long acting beta agonist (salmeterol) to constant dose of an inhaled corticosteroid (fluticasone propionate) in symptomatic subjects with asthma. The 12-month assessment of asthma control will provide key information on the efficacy and safety of the combination therapy. The safety measure will be an assessment of adverse events

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma [Completed]
This purpose of this study is to show the superiority and long term safety and efficacy of adding a long acting beta agonist (salmeterol) to constant dose of an inhaled corticosteroid (fluticasone propionate) in symptomatic subjects with asthma. The 12-month assessment of asthma control will provide key information on the efficacy and safety of the combination therapy. The safety measure will be an assessment of adverse events

FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects [Completed]
The purpose of this study is to address an Food Drug and Administration (FDA) request to provide safety data in pre-asthmatic patients, ages 6 months to <12 months, following administration of fluticasone propionate HFA.

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENTŪ DISKUSŪ and ADVAIRŪ DISKUSŪ in Patients With Persistent Asthma 12 Years of Age and Older [Active, not recruiting]
Each patient will participate in the study for approximately 7 weeks. Participation will include a screening period of up to 21 days and 4 treatment periods; each consisting of a 3-day/2-night inpatient period.

more trials >>

Reports of Suspected Flovent (Fluticasone Inhalation) Side Effects

Product Quality Issue (69)Dyspnoea (64)Drug Ineffective (50)Asthma (36)Cough (33)Dysphonia (31)Wheezing (16)Chest Discomfort (16)Pneumonia (16)Oropharyngeal Pain (14)more >>


PATIENT REVIEWS / RATINGS / COMMENTS

Based on a total of 1 ratings/reviews, Flovent has an overall score of 10. The effectiveness score is 10 and the side effect score is 10. The scores are on ten point scale: 10 - best, 1 - worst.
 

Flovent review by 31 year old female patient

  Rating
Overall rating:  
Effectiveness:   Highly Effective
Side effects:   No Side Effects
  
Treatment Info
Condition / reason:   asthma
Dosage & duration:   110 mcg (dosage frequency: twice a day) for the period of daily, since summer 2008 through present
Other conditions:   none
Other drugs taken:   albuterol, as needed
  
Reported Results
Benefits:   having suffered from asthma for most of my adult life, I began to rely on the albuterol (which should be only used as a rescue inhaler) multiple time per day. After beginning the Flovent inhaler, my asthma was almost non-existent.
Side effects:   It lists that mouth ulcers may occur, but upon following the instructions which say to rinse out the mouth directly after taking the medicine, I have suffered no side effects.
Comments:   You only need take two puffs in the morning, and another two puffs before going to bed. That's it!

See all Flovent reviews / ratings >>

Page last updated: 2016-05-25

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015